Login / Signup

Novel selective agonist of GPR18, PSB-KK-1415 exerts potent anti-inflammatory and anti-nociceptive activities in animal models of intestinal inflammation and inflammatory pain.

Adam FabisiakNatalia FabisiakAnna MokrowieckaEwa Malecka-PanasDamian JacenikRadzislaw KordekMarta ZielinskaKatarzyna Kieć-KononowiczJakub Fichna
Published in: Neurogastroenterology and motility : the official journal of the European Gastrointestinal Motility Society (2020)
We showed that GPR18 is worth considering as a potential treatment target in intestinal inflammation and inflammatory pain.
Keyphrases
  • oxidative stress
  • neuropathic pain
  • anti inflammatory
  • chronic pain
  • pain management
  • fatty acid
  • spinal cord
  • spinal cord injury
  • combination therapy
  • climate change